Real-world treatment in patients with HER2+ metastatic breast cancer: Treatment decisions in HER2+ mBC

por Colomer, R., Hall, P., Szkultecka-Debek, M., Bondi, R. C., Flinois, A., Auziere, S., Le Cléac’h, J. Y.
Publicado 2017